ARTICLE | Management Tracks
Plus: Martin Murphy stepping down as Syncona chair, and updates from Red Tree, OMass and Anagenex
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
November 17, 2023 2:17 AM UTC
Erik van den Berg became CEO of Memo Therapeutics AG, an infectious disease and cancer company. Van den Berg is chairman at Step Pharma S.A.S. and TargED Biopharmaceuticals B.V., and was CEO of AM-Pharma B.V.
CEO Chris Hollowood will take on the role of interim chairman of Syncona Ltd. (LSE:SYNC), after co-founder Martin Murphy stepped down. Murphy will continue to represent Syncona on the boards of Autolus Therapeutics plc (NASDAQ:AUTL), Anaveon AG and Clade Therapeutics Inc. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/650687/memo-names-erik-van-den-berg-as-ceo